Frank Marguet

USPTO Granted Patents = 15 (Patent Applications = 3)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 5.5

ph-index = 4

Forward Citations = 33(Granted Patents)

Location History:

Verrières le Buisson, FR (2001)
Verrieres le Buission, FR (2002)
Verrieres le Buisson, FR (2002 - 2016)
Paris, FR (2014 - 2021)

Company Filing History:

Years Active: 2001-2021

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10988524 - Modified relaxin B chain peptides and their therapeutic use (2021-04-27),

2. 10988523 - Modified lipidated Relaxin B chain peptides and their therapeutic use (2021-04-27),

3. 9233965 - 3,4-dihydropyrrolo[1,2-A]pyrazine-2,8(1H)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof for diseases involving casein kinase 1 epsilon and/or casein kinase 1 delta (2016-01-12),

4. 8835418 - Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application (2014-09-16),

5. 8791119 - [object Object] (2014-07-29),

6. 7569567 - 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-B]indole-1-carboxamide derivatives, their preparation and therapeutic use (2009-08-04),

7. 7547706 - 1H-pyrimido[4,5-b]indole derivatives, their preparation and therapeutic use (2009-06-16),

8. 7405306 - 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics (2008-07-29),

9. 7402682 - [object Object] (2008-07-22),

10. 7323467 - [object Object] (2008-01-29),

11. 7235554 - 3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b] indole-1-acetamide derivatives, preparation and use thereof in medicaments (2007-06-26),

12. 7109194 - 3-heteroaryl-3, 5-dihydro-4-oxo-4H-pyridazino[4, 5-b]indole-1-carboxamide derivatives their preparations and therapeutic use (2006-09-19),

13. 6451795 - 4-oxo-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-carboxamide derivatives, preparation and therapeutic use (2002-09-17),

14. 6395729 - Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating diseases related to the dysfunction of peripheral benzodiazepin receptors (2002-05-28),

15. 6262045 - 4-Oxo-3,5-dihydro-4H-pyridazino[4,5-b]-indole-1-acetamide derivatives, their preparation and their application in therapy (2001-07-17),

Title: Frank Marguet: A Visionary Inventor Pushing Boundaries in Patent Innovations

Introduction: Frank Marguet, a distinguished inventor based in Verrieres le Buisson, FR, has captivated the world with his passion for innovation and his unwavering commitment to creating groundbreaking patents and inventions. With a total of 15 patents under his belt, Marguet continues to push the boundaries of what is possible in the realm of patent technology.

Latest Patents: Among his latest patents is the groundbreaking discovery of modified lipidated Relaxin B chain peptides and their therapeutic use. This new biologically active single chain Relaxin peptide opens up a realm of possibilities in the field of pharmaceutical composition and medicament development.

Career Highlights: With an impressive career spanning various renowned companies, including Sanofi and Sanofi-Aventis, Marguet has showcased his exceptional talent and expertise in patent innovations. His contribution to the industry has not gone unnoticed, solidifying his reputation as a visionary inventor.

Collaborations: Throughout his illustrious career, Marguet has collaborated with esteemed individuals in the field, including Jacques Froissant and Frederic Puech. These collaborations have led to the creation of pioneering inventions that have revolutionized the industry.

Conclusion: Frank Marguet's relentless drive to innovate and his fervent dedication to creating transformative patents have established him as a prominent figure in the world of patent technology. His passion for pushing boundaries and his visionary approach to invention continue to shape the industry and inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.